(88 days)
No
The summary describes a spinal system with patient-specific rods that are bent before surgery based on surgeon design, not through AI/ML analysis. There are no mentions of AI, ML, or related concepts.
Yes
The device is described as "intended to provide immobilization of spinal segments as an adjunct to fusion" and "restore the integrity of the spinal column," which are therapeutic actions.
No
The device is described as a spinal system intended for immobilization and restoration of the spinal column as an adjunct to fusion, not for diagnosing conditions.
No
The device description explicitly states it consists of various hardware components like rods, hooks, screws, and plates, and mentions the materials used for these implants.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use clearly describes a surgical implant system designed to provide mechanical support and stabilization to the spine. This is a therapeutic device, not a diagnostic one.
- Device Description: The description details physical components like rods, screws, hooks, and plates made of various biocompatible materials. These are all components of a surgical implant.
- Lack of Diagnostic Elements: There is no mention of the device being used to analyze biological samples (blood, tissue, etc.) or to provide information for the diagnosis of a disease or condition.
- Anatomical Site: The device is used directly on the spine, which is consistent with a surgical implant.
- Performance Studies: The performance studies described are mechanical tests (compression, torsion) to evaluate the structural integrity of the implant, not studies related to diagnostic accuracy.
In summary, the PASS OCT spinal system is a surgical implant intended for the treatment of spinal instabilities, not for in vitro diagnostic purposes.
N/A
Intended Use / Indications for Use
The PASS OCT spinal system is intended to provide immobilization of spinal segments as an adjunct to fusion for the following acute and chronic instabilities of the craniocervical spine (C1 to C7) and the thoracic spine from T1-T3: traumatic spinal fractures and/or traumatic dislocations; instability or deformity; failed previous fusions (e.g., pseudarthrosis); tumors involving the cervical spine; and degenerative disease, including intractable radiculopathy and/or myelopathy, neck and/or arm pain of discogenic origin as confirmed by radiographic studies, and degenerative disease of the facets with instability. The PASS OCT spinal system is also intended to restore the integrity of the spinal column even in the absence of fusion for a limited time period in patients with advanced stage tumors involving the cervical spine in whom life expectancy is of insufficient duration to permit achievement of fusion.
In order to achieve additional levels of fixation, the PASS OCT spinal system may be connected to the PASS LP spinal system with the dual diameter rods. Refer to the PASS LP spinal system package insert for a list of the PASS LP spinal system indications of use.
Product codes (comma separated list FDA assigned to the subject device)
NKG, KWP
Device Description
The PASS OCT Spinal System is a posterior system, which consists of a variety of shapes and sizes of rods, hooks, polyaxial screws, occipital plates, occipital bone screws, and connection components, which can be rigidly locked to the rod in a variety of configurations. See package insert of the system for labeling limitations.
The implants are manufactured in titanium alloy Ti-6AI-4V ELI conforming to ISO 5832-3 specifications and ASTM F136 specifications, in PEEK OPTIMA LT1 conforming to ASTM F2026 specifications and in cobalt-chromium molybdenum alloy Co-Cr28Mo6 that conforms to ISO 5832-12 and ASTM F1537 specifications, and also CP Titanium according to ASTM F67 and ISO 5832-2 specifications.
Function: The PASS OCT spinal system was developed as an implant:
- · To provide immobilization and stabilization of posterior spinal segments
- to augment the development of a solid spinal fusion
- · to provide stability to ease fusion
- to be mechanically resistant to allow the fusion of the operated level
The purpose of this submission is to add Patient Specific, UNiD OCT rods. The Patient Specific Rod is a rod bent before surgery by MEDICREA, following the design defined by the surgeon only specific to a unique patient.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
craniocervical spine (C1 to C7), thoracic spine from T1-T3
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
The components of the PASS OCT Patient Specific Rods were mechanically evaluated in static and dynamic compression and static and dynamic torsion tests following the ASTM F2706-08. Each time, the mechanical test was conducted on a justified worst case.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 888.3075 Posterior cervical screw system.
(a)
Identification. Posterior cervical screw systems are comprised of multiple, interconnecting components, made from a variety of materials that allow an implant system to be built from the occiput to the upper thoracic spine to fit the patient's anatomical and physiological requirements, as determined by preoperative cross-sectional imaging. Such a spinal assembly consists of a combination of bone anchors via screws (i.e., occipital screws, cervical lateral mass screws, cervical pedicle screws, C2 pars screws, C2 translaminar screws, C2 transarticular screws), longitudinal members (e.g., plates, rods, including dual diameter rods, plate/rod combinations), transverse or cross connectors, interconnection mechanisms (e.g., rod-to-rod connectors, offset connectors), and closure mechanisms (e.g., set screws, nuts). Posterior cervical screw systems are rigidly fixed devices that do not contain dynamic features, including but not limited to: non-uniform longitudinal elements or features that allow more motion or flexibility compared to rigid systems.Posterior cervical screw systems are intended to provide immobilization and stabilization of spinal segments in patients as an adjunct to fusion for acute and chronic instabilities of the cervical spine and/or craniocervical junction and/or cervicothoracic junction such as: (1) Traumatic spinal fractures and/or traumatic dislocations; (2) deformities; (3) instabilities; (4) failed previous fusions (
e.g., pseudarthrosis); (5) tumors; (6) inflammatory disorders; (7) spinal degeneration, including neck and/or arm pain of discogenic origin as confirmed by imaging studies (radiographs, CT, MRI); (8) degeneration of the facets with instability; and (9) reconstruction following decompression to treat radiculopathy and/or myelopathy. These systems are also intended to restore the integrity of the spinal column even in the absence of fusion for a limited time period in patients with advanced stage tumors involving the cervical spine in whom life expectancy is of insufficient duration to permit achievement of fusion.(b)
Classification. Class II (special controls). The special controls for posterior cervical screw systems are:(1) The design characteristics of the device, including engineering schematics, must ensure that the geometry and material composition are consistent with the intended use.
(2) Nonclinical performance testing must demonstrate the mechanical function and durability of the implant.
(3) Device components must be demonstrated to be biocompatible.
(4) Validation testing must demonstrate the cleanliness and sterility of, or the ability to clean and sterilize, the device components and device-specific instruments.
(5) Labeling must include the following:
(i) A clear description of the technological features of the device including identification of device materials and the principles of device operation;
(ii) Intended use and indications for use including levels of fixation;
(iii) Device specific warnings, precautions, and contraindications that include the following statements:
(A) “Precaution: Preoperative planning prior to implantation of posterior cervical screw systems should include review of cross-sectional imaging studies (
e.g., CT and/or MRI) to evaluate the patient's cervical anatomy including the transverse foramen, neurologic structures, and the course of the vertebral arteries. If any findings would compromise the placement of these screws, other surgical methods should be considered. In addition, use of intraoperative imaging should be considered to guide and/or verify device placement, as necessary.”(B) “Precaution: Use of posterior cervical pedicle screw fixation at the C3 through C6 spinal levels requires careful consideration and planning beyond that required for lateral mass screws placed at these spinal levels, given the proximity of the vertebral arteries and neurologic structures in relation to the cervical pedicles at these levels.”
(iv) Identification of magnetic resonance (MR) compatibility status;
(v) Cleaning and sterilization instructions for devices and instruments that are provided non-sterile to the end user, and;
(vi) Detailed instructions of each surgical step, including device removal.
0
Image /page/0/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular seal with the words "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" arranged around the perimeter. Inside the circle is a stylized image of three human profiles facing to the right, overlapping each other to create a sense of depth and unity.
Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002
January 29, 2016
Medicrea International Mr. David Ryan VP, Product Development and Marketing 14 Porte du Grand Lyon 01700 Nevron FRANCE
Re: K153169 Trade/Device Name: PASS OCT Patient Specific Rods Regulatory Class: Unclassified Product Code: NKG, KWP Dated: October 30, 2015 Received: November 2, 2015
Dear Mr. Ryan:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug. and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Parts 801); medical device reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set
1
forth in the quality systems (OS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm. Also, please note the regulation entitled. "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.
Sincerely yours,
Mark N. Melkerson -S
Mark N. Melkerson Director Division of Orthopedic Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
2
DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration
Indications for Use
Form Approved: OMB No. 0910-0120 Expiration Date: January 31, 2017 See PRA Statement below.
510(k) Number (if known) K153169
Device Name PASS OCT Patient Specific Rods
Indications for Use (Describe)
The PASS OCT spinal system is intended to provide immobilization of spinal segments as an adjunct to fusion for the following acute and chronic instabilities of the craniocervical spine (C1 to C7) and the thoracic spine from T1-T3: traumatic spinal fractures and/or traumatic dislocations; instability or deformity; failed previous fusions (e.g., pseudarthrosis); tumors involving the cervical spine; and degenerative disease, including intractable radiculopathy and/or myelopathy, neck and/or arm pain of discogenic origin as confirmed by radiographic studies, and degenerative disease of the facets with instability. The PASS OCT spinal system is also intended to restore the integrity of the spinal column even in the absence of fusion for a limited time period in patients with advanced stage tumors involving the cervical spine in whom life expectancy is of insufficient duration to permit achievement of fusion.
In order to achieve additional levels of fixation, the PASS OCT spinal system may be connected to the PASS LP spinal system with the dual diameter rods. Refer to the PASS LP spinal system package insert for a list of the PASS LP spinal system indications of use.
| Type of Use (Select one or both, as applicable) | |
|---|---|
| ☒ Prescription Use (Part 21 CFR 801 Subpart D) | ☐ Over-The-Counter Use (21 CFR 801 Subpart C) |
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services
Food and Drug Administration
Office of Chief Information Officer
Paperwork Reduction Act (PRA) Staff
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
3
510(k) SUMMARY
MEDICREA INTERNATIONAL's PASS OCT Patient Specific Rods
In accordance with 21 CFR 807.92 of the Federal Code of Requlations the following 510(k) summary is submitted to add the ranges of Patient Specific Rods to PASS OCT Spinal System.
Date Prepared: 30 October 2015
-
- Submitter:
| Submitter: | Contact Person: |
|---|---|
| MEDICREA INTERNATIONAL | David RYAN |
| 14 Porte du Grand Lyon | MEDICREA INTERNATIONAL |
| NEYRON 01700 | 14 Porte du Grand Lyon |
| NEYRON 01700 FR | |
| Ph +33 4 72 01 87 87 |
-
- Trade name: PASS OCT Patient Specific Rods
Regulatory Identification/Classification:
Orthosis, Cervical Pedicle Screw Spinal Fixation Product Code: NKG Unclassified, Pre-Amendment
Spinal Interlaminal Fixation Orthosis Requlation Number: 21CFR 888.3050 Product Code: KWP Class II
3. Predicate or leqally marketed devices which are substantially equivalent:
Primary predicate:
PASS OCT Spinal System, (MEDICREA INTERNATIONAL, K150918) . No recall recorded for this product.
Reference Device:
- PASS LP Spinal System - Patient Specific Rods, (MEDICREA INTERNATIONAL, K140738)
4. Description of the device:
The PASS OCT Spinal System is a posterior system, which consists of a variety of shapes and sizes of rods, hooks, polyaxial screws, occipital plates, occipital bone screws, and connection components, which can be rigidly locked to the rod in a variety of configurations. See package insert of the system for labeling limitations.
The implants are manufactured in titanium alloy Ti-6AI-4V ELI conforming to ISO 5832-3 specifications and ASTM F136 specifications, in PEEK OPTIMA LT1 conforming to ASTM F2026 specifications and in cobalt-chromium molybdenum alloy Co-Cr28Mo6 that conforms to ISO 5832-12 and ASTM F1537 specifications, and also CP Titanium according to ASTM F67 and ISO 5832-2 specifications.
4
Function: The PASS OCT spinal system was developed as an implant:
- · To provide immobilization and stabilization of posterior spinal segments
- to augment the development of a solid spinal fusion
- · to provide stability to ease fusion
- to be mechanically resistant to allow the fusion of the operated level
The purpose of this submission is to add Patient Specific, UNiD OCT rods. The Patient Specific Rod is a rod bent before surgery by MEDICREA, following the design defined by the surgeon only specific to a unique patient.
5. Indication for Use
The PASS OCT Spinal System is intended to provide immobilization of spinal segments as an adjunct to fusion for the following acute and chronic instabilities of the craniocervical junction, the cervical spine (C1 to C7) and the thoracic spine from T1-T3: traumatic spinal fractures and/or traumatic dislocations; instability or deformity; failed previous fusions (e.g., pseudarthrosis); turnors involving the cervical spine; and degenerative disease, including intractable radiculopathy and/or myelopathy, neck and/or arm pain of discogenic origin as confirmed by radiographic studies, and degenerative disease of the facets with instability. The PASS OCT Spinal System is also intended to restore the integrity of the spinal column even in the absence of fusion for a limited time period in patients with advanced stage tumors involving the cervical spine in whom life expectancy is of insufficient duration to permit achievement of fusion.
In order to achieve additional levels of fixation, the PASS OCT® Spinal System may be connected to the PASS LP ® Spinal System rods with the dual diameter rods. Refer to the PASS LP ® Spinal System package insert for a list of the PASS LP ® Spinal System indications of use.
Substantial equivalence claimed to predicate devices 6.
The PASS OCT Patient Specific Rods are technologically similar to the already cleared PASS OCT Spinal System Rods in terms of intended use, materials used, mechanical safety and performances
The table below compares the features and characteristics of PASS OCT components to their predicate devices.
| Device | MEDICREA INTERNATIONAL
(subject device) | MEDICREA INTERNATIONAL
PASS OCT Spinal System |
|--------------------|-------------------------------------------------------------------|-------------------------------------------------------------------|
| 510(k) number | Unknown | K150918 |
| Intended use | | |
| Occipital | Yes | Yes |
| Cervical | Yes | Yes |
| Thoracic | Yes | Yes |
| Components | | |
| Anchorage means | -Polyaxial screws
- Polyaxial hooks
- Occipital bone screws | -Polyaxial screws
- Polyaxial hooks
- Occipital bone screws |
| Rods diameter | Ø3.5 mm | Ø3.5 mm |
| Dual Diameter Rods | Ø3.5mm/ Ø5.5mm
Ø3.5mm/ Ø6.0 mm | Ø3.5mm/ Ø5.5mm
Ø3.5mm/ Ø6.0 mm |
| Straight rods | No | Yes |
| Pre-bent rods | No | Yes |
5
| Patient Specific Rods,
| pre-bent before surgery | Yes | No |
|---|---|---|
| --------------------------------------------------- | ----- | ---- |
| Device | MEDICREA INTERNATIONAL
(subject device) | MEDICREA INTERNATIONAL
PASS OCT Spinal System |
|-----------|----------------------------------------------------------------------|----------------------------------------------------------------------|
| Materials | | |
| | Titanium Alloy (Ti-6Al-4V)
according to ASTM F136 & ISO
5832-3 | Titanium Alloy (Ti-6Al-4V)
according to ASTM F136 & ISO
5832-3 |
| | -Grade Titanium according to
ASTM F67-13 & ISO 5832-2 | -Grade Titanium according to
ASTM F67-13 & ISO 5832-2 |
| | PEEK OPTIMA LT1
conforming to ASTM F2026 | PEEK OPTIMA LT1 conforming to
ASTM F2026 |
| | Co-Cr 28Mo6 alloy 1 (following
the ASTMF1537 | Co-Cr 28Mo6 alloy 1 (following
the ASTMF1537 |
7. Non-clinical Test Summary:
The components of the PASS OCT Patient Specific Rods were mechanically evaluated in static and dynamic compression and static and dynamic torsion tests following the ASTM F2706-08. Each time, the mechanical test was conducted on a justified worst case.
8. Clinical Test Summary
Published literature was used to demonstrate substantial equivalence
9. Conclusions Non clinical and Clinical
The PASS OCT Patient Specific Rods components are substantially equivalent to legally marketed predicate device.